Research programme: metabotropic glutamate receptor modulator - Prescient
Alternative Names: PRE 703Latest Information Update: 17 Jan 2011
Price :
$50 *
At a glance
- Originator Prescient NeuroPharma
- Class Anxiolytics; Small molecules
- Mechanism of Action Metabotropic glutamate receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Anxiety disorders
Most Recent Events
- 17 Jan 2011 No development reported - Preclinical for Anxiety disorders in Canada (unspecified route)
- 05 Oct 2005 PRE 703 is available for licensing
- 16 Sep 2005 This compound is still in active development